In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tissue, Cell-Based Product Reg Needs Some Clarification - FDA Staffers

This article was originally published in The Gray Sheet

Executive Summary

FDA's proposed rule to establish regulations on human cellular or tissue-based medical equipment requires further clarification, agency staffers acknowledged.

You may also be interested in...



Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita

Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery

Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita

Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery

Tissue Regs On Horizon Despite Manufacturer Concerns

FDA should regulate threaded cortical bone dowels as a device, rather than a tissue, because it is indicated for a specific use, Stryker Biotech maintains in comments to the agency.

Related Content

UsernamePublicRestriction

Register

MT013712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel